A comparative histological evaluation of the ablations produced by microwave, cryotherapy and radiofrequency in the liver
- 1 February 2009
- journal article
- research article
- Published by Elsevier BV in Pathology
- Vol. 41 (2), 168-172
- https://doi.org/10.1080/00313020802579292
Abstract
Complete tumour cell death is necessary for any ablative technique to be successful. Microwave tissue ablation (MTA), radiofrequency (RF) and cryotherapy (CT) are three methods of destroying liver tumours in situ. Unlike MTA, RF and CT rely on conduction of the thermal insult for their cytotoxicity, potentially affecting lesion uniformity. The aim of this study was to compare the uniformity of demarcation of lesions induced by MTA, RF and CT in the rat liver. Twenty-one rats were assigned to each of the three ablative modalities. All specimens exhibited macroscopically well demarcated lesions. Microscopically, the most clearly deli- neated lesions were induced by MTA with no intra-lesional viable hepatocytes or peri-vascular survival. All vessels and bile ducts had undergone complete necrosis. CT specimens showed more prominent inflammation at the lesion edge than MTA and peri-vascular hepatocyte survival within the ablated volumes. RF showed hepatocyte survival in the ablated area and conspicuous peri-vascular hepatocyte survival with evidence of a very irregular lesion edge. Cell viability was only assessed with H&E staining and not immunocytochemically. Unlike RF and CT, MTA induced microscopically well-demarcated lesions, with no intralesional hepatocyte survival. Intralesional cell survival in RF and CT may be due to the relatively prolonged treatment times needed, allowing thermal energy to dissipate via blood flow. This is known as the heat sink effect and may contribute to the high local recurrence rates following treatment of larger tumours with RF and CT.Keywords
This publication has 13 references indexed in Scilit:
- A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytomaBMC Endocrine Disorders, 2004
- A Comparison of Biochemical Tests for Pheochromocytoma: Measurement of Fractionated Plasma Metanephrines Compared with the Combination of 24-Hour Urinary Metanephrines and CatecholaminesJournal of Clinical Endocrinology & Metabolism, 2003
- Pheochromocytoma as an endocrine emergency.Reviews in Endocrine and Metabolic Disorders, 2003
- Pheochromocytoma in a Patient With End-Stage Renal DiseaseMayo Clinic Proceedings, 2001
- Understanding Catecholamine Metabolism as a Guide to the Biochemical Diagnosis of PheochromocytomaReviews in Endocrine and Metabolic Disorders, 2001
- Plasma Metanephrines Are Markers of Pheochromocytoma Produced by Catechol-O-Methyltransferase Within TumorsJournal of Clinical Endocrinology & Metabolism, 1998
- Plasma Metanephrines in the Diagnosis of PheochromocytomaAnnals of Internal Medicine, 1995
- Plasma Metadrenalines: Do they Provide Useful Information about Sympatho-Adrenal Function and Catecholamine Metabolism?Clinical Science, 1995
- Diagnostic Considerations in Pheochromocytoma and Chronic Hemodialysis: Case Report and Review of the LiteratureAmerican Journal of Nephrology, 1995
- Simultaneous liquid-chromatographic analysis for 4-hydroxy-3-methoxymandelic acid and 4-hydroxy-3-methoxyphenylacetic acid in urine.Clinical Chemistry, 1980